4.5 Article

Melanocortin 1 receptor mutations impact differentially on signalling to the cAMP and the ERK mitogen-activated protein kinase pathways

Journal

FEBS LETTERS
Volume 583, Issue 19, Pages 3269-3274

Publisher

WILEY
DOI: 10.1016/j.febslet.2009.09.023

Keywords

Melanocortin 1 receptor; MC1R variant; cAMP; ERK; Melanoma; Melanocyte

Funding

  1. Comision Interministerial de Ciencia y Tecnologia (CICYT), Spain [SAF2006-11206]
  2. European Community
  3. Comunidad Autonoma de la Region de Murcia (CARM) [464/2008]
  4. Plan de Ciencia y Tecnologia
  5. Fundacion Seneca, CARM

Ask authors/readers for more resources

Melanocortin 1 receptor (MC1R), a Gs protein-coupled receptor expressed in melanocytes, is a major determinant of skin pigmentation, phototype and cancer risk. MC1R activates cAMP and mitogen-activated protein kinase ERK1/ERK2 signalling. When expressed in rat pheochromocytoma cell line cells, the R151C, R160W and D294H MC1R variants associated with melanoma and impaired cAMP signalling mediated ERK activation and ERK-dependent, agonist-induced neurite outgrowth comparable with wild-type. Dose-response curves for ERK activation and cAMP production indicated higher sensitivity of the ERK response. Thus, the melanoma-associated MC1R mutations impact differently on cAMP and ERK signalling, suggesting that cAMP is not responsible for functional coupling of MC1R to the ERK cascade. (C) 2009 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available